CPT® Code 80161

The CPT® Code 80161 refers to a laboratory test specifically designed to monitor the therapeutic levels of carbamazepine-10,11-epoxide (CBZ10-11), which is the active metabolite of the anticonvulsant medication carbamazepine (CBZ). Carbamazepine is utilized primarily for the treatment of epilepsy and certain mood disorders, but it possesses neurotoxic properties that necessitate careful monitoring of its levels in the bloodstream. The test is crucial for assessing the potential for toxicity, which can arise from an overdose of carbamazepine. Symptoms of toxicity include serious conditions such as arrhythmias, hypotension, respiratory depression, seizures, and even coma. The therapeutic range for total carbamazepine serum levels is established between 4.0 to 12.0 mcg/mL, while levels reaching 15.0 mcg/mL are considered critical and indicative of toxicity. Additionally, when the serum concentration of the metabolite exceeds 40% of the parent drug, there is a similar risk of toxicity. For the metabolite carbamazepine-10,11-epoxide, the clinically acceptable serum concentration range is defined as 0.4 to 4.0 mcg/mL, with concentrations equal to or greater than 8.0 mcg/mL classified as toxic. To conduct this test, a blood sample is drawn approximately 12 hours after the patient's last dose of carbamazepine. The sample is then analyzed using high-performance liquid chromatography (HPLC), a precise method for separating and quantifying compounds in a mixture. Monitoring the levels of the active metabolite is essential, as patients may present with total serum concentrations of carbamazepine that fall within the therapeutic range, yet still produce significant levels of its active metabolite, thereby increasing the risk of dangerous toxicity.